Gundogan, CihanGuzel, YunusCan, CananAlabalik, UlasKomek, Halil2024-04-242024-04-2420210363-97621536-0229https://doi.org/10.1097/RLU.0000000000003594https://hdl.handle.net/11468/17336Ga-68-fibroblast activation protein-specific inhibitor (FAPI)-04 PET/CT was performed in a patient with left lower outer quadrant breast cancer who had F-18-FDG PET/CT imaging. Ga-68-FAPI-04 PET/CT showed higher accumulation of radiotracer in primary tumor and axillary lymph nodes than F-18-FDG PET/CT. In addition, focal increased FAPI uptake was observed in another nodular lesion in the lower inner quadrant in the same breast, which was considered malignant. However, Tru-Cut biopsy of this lesion was reported as benign lymphoid tissue. This case showed that all FAPI accumulation in breast tissue should not be interpreted in favor of malignancy; histopathological confirmation is required.eninfo:eu-repo/semantics/closedAccessF-18-FdgGa-68-FapiBreast CancerPet/CtFalse-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast CancerFalse-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast CancerEditorial468E433E435WOS:0006696185000082-s2.0-851106228253378229510.1097/RLU.0000000000003594Q3Q1